# J.P. Morgan Healthcare Conference 2026: What Experts Can Learn from the Health Industry's Stage

Author: Marin Niehues, Stage Starter · Published: 2026-01-28 · Updated: 2026-11-16
Topic: Finding Conferences (https://stage-starter.com/blog/topic/finding-conferences/)
Source: https://stage-starter.com/blog/jpm-2026-speakers/

The 44th J.P. Morgan Healthcare Conference ran from January 12 to 15, 2026, in San Francisco. Its program consists of company presentations in which large corporations and young firms report on commercial performance, clinical progress, regulatory milestones and strategic priorities. For you as a professional, the week is therefore above all a topic barometer: it shows what an audience of investors and executives wants to hear and how the presenters tell it.

## Every claim needs a number

Evaluate's analysis of the first conference day (published January 13) reads in large parts like a collection of key figures. Johnson & Johnson named a growth target of 5 to 7 percent a year from 2023 to the end of the decade and pointed to a dozen launches in that period. Alnylam spoke about more than 300,000 patients with ATTR-CM worldwide, 80 percent of whom are still undiagnosed. Sarepta put the 2025 revenue of its marketed products at more than $1.86 billion.

Each of these numbers answers a question the audience already has: how big is the market, how far along is the company, where is the remaining potential? At Alnylam the message sits in the gap itself, because the 80 percent without a diagnosis describes the size of the task. If you want to reach a stage as an expert or consultant, you need the same kind of proof from your own practice, such as the number of projects you supported, the weeks you saved or the share of cases in which an approach worked.

## The audience brings its worries

Alongside the company presentations, policy had its say in San Francisco. Advisory Board summarized reports from STAT and others on January 20: Mehmet Oz, administrator of the U.S. agency CMS, met with four senior staff members and several hundred hospital and insurance leaders. He said the coming Medicaid cuts would not be felt for at least a year and a half. David Joyner, CEO of Hill Physicians Medical Group, described the mood of attendees as skeptical and pessimistic about Medicaid and declining ACA enrollment, but curious and optimistic about the agency's push for new innovation.

The finance chiefs of the health systems set the tone as well. Kevin Smith of SSM Health named stabilizing as the focus. Greg Hoffman of Providence said some of the system's 51 hospitals might need a different purpose or different sponsors. A talk about unchecked growth would have missed the mood in that room. Program committees look for the same thing: they want contributions that pick up a worry of the target audience. How they judge submissions is covered in our article on what a program committee looks for.

## AI is in almost every topic, a use case makes the difference

The same report says Anthropic introduced Claude for Healthcare in San Francisco, with an infrastructure built for HIPAA. Banner Health, Novo Nordisk and AbbVie already use Claude. Elation Health built it into its electronic health record to summarize charts. Hippocratic AI acquired Grove AI to expand into life sciences. Evaluate also lists growth with disciplined costs and licensing deals that close capability gaps among the first day's themes.

For submissions, this means the term AI alone does not set a talk apart. The examples above have a name, an application and a customer. Banner Health and Elation Health are concrete cases that an audience can orient itself by. Your abstract gains when it also names a case: which task was solved at which company with which result.

## What to take into your next submission

Before you open the form, write down one number from your work that a listener can repeat in a single sentence. Add the worry your audience has right now, in the words it would use itself. Finally, choose a case with a name or at least an industry and a size. These building blocks form the basis of a submission that also works outside San Francisco, at healthcare conferences as well as on cross-industry stages.

Sources: [A clearer view from JPM 2026 day one](https://www.evaluate.com/blog/a-clearer-view-from-jpm-2026-day-one/), Evaluate, January 13, 2026. [Top Biotech Players REGN, INCY, PTCT Among Participants At J.P.Morgan Healthcare Conference 2026](https://www.rttnews.com/amp/3609103/top-biotech-players-regn-incy-ptct-among-participants-at-j-p-morgan-healthcare-conference-2026.aspx), RTTNews, January 9, 2026. [Daily Briefing: JPM health](https://www.advisory.com/daily-briefing/2026/01/20/jpm-health), Advisory Board, January 20, 2026.
